Bio-Rad Laboratories Inc Class A (BIO)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$298.04

Buy

$302.89

arrow-up$1.83 (+0.61%)

Prices updated at 19 Dec 2025, 14:30 EST

Prices minimum 15 mins delay

Prices in USD

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.

S&P 500

-%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	2,671m	2,567m
	1,427m	1,379m
	338m	269m
	12.65	10.48
	-637m	-1,844m
	-655m	-2,142m
Sales, General and administrative	842m	814m
Interest expenses	49m	49m
Provision for income taxes	-213m	-498m
Operating expenses	1,089m	1,110m
Income before taxes	-850m	-2,342m
Net income available to common shareholders	-637m	-1,844m
	-21.82	-65.36
Net interest income	52m	33m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-21.82	-65.36
Free cash flow per share	7.5749	7.8754
Book value/share	295.1143	267.3171
Debt equity ratio	0.156111	0.202731

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	3,048m	3,030m
Current liabilities	523m	468m
Total capital	9,940m	7,770m
Total debt	1,405m	1,375m
Total equity	8,741m	6,569m
Total non current liabilities	-	-
Loans	1,199m	1,200m
Total assets	12,299m	9,364m
Total liabilities	-	-
Cash and cash equivalents	404m	488m
Common stock	29m	28m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	435m	404m
Cash dividends paid	-	-
	218m	266m
Investments (gains) losses	20m	-160m
	404m	490m
Net income	-	-
	375m	455m
	-157m	-189m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.